Table of Contents 1 Market Overview 1.1 Pontine Glioma Drug Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Pontine Glioma Drug Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 8H-9 1.2.3 A-10 1.2.4 AdRTSIL-12 1.2.5 Afatinib Dimaleate 1.2.6 AZD-1775 1.2.7 Others 1.3 Market Analysis by Application 1.3.1 Overview: Global Pontine Glioma Drug Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Overview of Global Pontine Glioma Drug Market 1.4.1 Global Pontine Glioma Drug Market Status and Outlook (2015-2025) 1.4.2 North America (United States, Canada and Mexico) 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy) 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.5 South America, Middle East & Africa 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Arog Pharmaceuticals, Inc. 2.1.1 Arog Pharmaceuticals, Inc. Details 2.1.2 Arog Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 Arog Pharmaceuticals, Inc. SWOT Analysis 2.1.4 Arog Pharmaceuticals, Inc. Product and Services 2.1.5 Arog Pharmaceuticals, Inc. Pontine Glioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.2 Medicenna Therapeutics, Inc. 2.2.1 Medicenna Therapeutics, Inc. Details 2.2.2 Medicenna Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 Medicenna Therapeutics, Inc. SWOT Analysis 2.2.4 Medicenna Therapeutics, Inc. Product and Services 2.2.5 Medicenna Therapeutics, Inc. Pontine Glioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.3 Burzynski Research Institute, Inc. 2.3.1 Burzynski Research Institute, Inc. Details 2.3.2 Burzynski Research Institute, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Burzynski Research Institute, Inc. SWOT Analysis 2.3.4 Burzynski Research Institute, Inc. Product and Services 2.3.5 Burzynski Research Institute, Inc. Pontine Glioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.4 Sanofi 2.4.1 Sanofi Details 2.4.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 Sanofi SWOT Analysis 2.4.4 Sanofi Product and Services 2.4.5 Sanofi Pontine Glioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.5 Loxo Oncology, Inc. 2.5.1 Loxo Oncology, Inc. Details 2.5.2 Loxo Oncology, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Loxo Oncology, Inc. SWOT Analysis 2.5.4 Loxo Oncology, Inc. Product and Services 2.5.5 Loxo Oncology, Inc. Pontine Glioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.6 Novogen Limited 2.6.1 Novogen Limited Details 2.6.2 Novogen Limited Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 Novogen Limited SWOT Analysis 2.6.4 Novogen Limited Product and Services 2.6.5 Novogen Limited Pontine Glioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.7 Medivation, Inc. 2.7.1 Medivation, Inc. Details 2.7.2 Medivation, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.7.3 Medivation, Inc. SWOT Analysis 2.7.4 Medivation, Inc. Product and Services 2.7.5 Medivation, Inc. Pontine Glioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 3 Sales, Revenue and Market Share by Manufacturer 3.1 Global Pontine Glioma Drug Sales and Market Share by Manufacturer (2018-2019) 3.2 Global Pontine Glioma Drug Revenue and Market Share by Manufacturer (2018-2019) 3.3 Market Concentration Rate 3.3.1 Top 3 Pontine Glioma Drug Manufacturer Market Share in 2019 3.3.2 Top 6 Pontine Glioma Drug Manufacturer Market Share in 2019 3.4 Market Competition Trend 4 Global Market Analysis by Regions 4.1 Global Pontine Glioma Drug Sales, Revenue and Market Share by Regions 4.1.1 Global Pontine Glioma Drug Sales and Market Share by Regions (2015-2020) 4.1.2 Global Pontine Glioma Drug Revenue and Market Share by Regions (2015-2020) 4.2 North America Pontine Glioma Drug Sales and Growth Rate (2015-2020) 4.3 Europe Pontine Glioma Drug Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific Pontine Glioma Drug Sales and Growth Rate (2015-2020) 4.5 South America Pontine Glioma Drug Sales and Growth Rate (2015-2020) 4.6 Middle East and Africa Pontine Glioma Drug Sales and Growth Rate (2015-2020) 5 North America by Country 5.1 North America Pontine Glioma Drug Sales, Revenue and Market Share by Country 5.1.1 North America Pontine Glioma Drug Sales and Market Share by Country (2015-2020) 5.1.2 North America Pontine Glioma Drug Revenue and Market Share by Country (2015-2020) 5.2 United States Pontine Glioma Drug Sales and Growth Rate (2015-2020) 5.3 Canada Pontine Glioma Drug Sales and Growth Rate (2015-2020) 5.4 Mexico Pontine Glioma Drug Sales and Growth Rate (2015-2020) 6 Europe by Country 6.1 Europe Pontine Glioma Drug Sales, Revenue and Market Share by Country 6.1.1 Europe Pontine Glioma Drug Sales and Market Share by Country (2015-2020) 6.1.2 Europe Pontine Glioma Drug Revenue and Market Share by Country (2015-2020) 6.2 Germany Pontine Glioma Drug Sales and Growth Rate (2015-2020) 6.3 UK Pontine Glioma Drug Sales and Growth Rate (2015-2020) 6.4 France Pontine Glioma Drug Sales and Growth Rate (2015-2020) 6.5 Russia Pontine Glioma Drug Sales and Growth Rate (2015-2020) 6.6 Italy Pontine Glioma Drug Sales and Growth Rate (2015-2020) 7 Asia-Pacific by Regions 7.1 Asia-Pacific Pontine Glioma Drug Sales, Revenue and Market Share by Regions 7.1.1 Asia-Pacific Pontine Glioma Drug Sales and Market Share by Regions (2015-2020) 7.1.2 Asia-Pacific Pontine Glioma Drug Revenue and Market Share by Regions (2015-2020) 7.2 China Pontine Glioma Drug Sales and Growth Rate (2015-2020) 7.3 Japan Pontine Glioma Drug Sales and Growth Rate (2015-2020) 7.4 Korea Pontine Glioma Drug Sales and Growth Rate (2015-2020) 7.5 India Pontine Glioma Drug Sales and Growth Rate (2015-2020) 7.6 Southeast Asia Pontine Glioma Drug Sales and Growth Rate (2015-2020) 7.7 Australia Pontine Glioma Drug Sales and Growth Rate (2015-2020) 8 South America by Country 8.1 South America Pontine Glioma Drug Sales, Revenue and Market Share by Country 8.1.1 South America Pontine Glioma Drug Sales and Market Share by Country (2015-2020) 8.1.2 South America Pontine Glioma Drug Revenue and Market Share by Country (2015-2020) 8.2 Brazil Pontine Glioma Drug Sales and Growth Rate (2015-2020) 8.3 Argentina Pontine Glioma Drug Sales and Growth Rate (2015-2020) 9 Middle East & Africa by Countries 9.1 Middle East & Africa Pontine Glioma Drug Sales, Revenue and Market Share by Country 9.1.1 Middle East & Africa Pontine Glioma Drug Sales and Market Share by Country (2015-2020) 9.1.2 Middle East & Africa Pontine Glioma Drug Revenue and Market Share by Country (2015-2020) 9.2 Saudi Arabia Pontine Glioma Drug Sales and Growth Rate (2015-2020) 9.3 Turkey Pontine Glioma Drug Sales and Growth Rate (2015-2020) 9.4 Egypt Pontine Glioma Drug Sales and Growth Rate (2015-2020) 9.5 South Africa Pontine Glioma Drug Sales and Growth Rate (2015-2020) 10 Market Segment by Type 10.1 Global Pontine Glioma Drug Sales and Market Share by Type (2015-2020) 10.2 Global Pontine Glioma Drug Revenue and Market Share by Type (2015-2020) 10.3 Global Pontine Glioma Drug Price by Type (2015-2020) 11 Global Pontine Glioma Drug Market Segment by Application 11.1 Global Pontine Glioma Drug Sales Market Share by Application (2015-2020) 11.2 Global Pontine Glioma Drug Revenue Market Share by Application (2015-2020) 11.3 Global Pontine Glioma Drug Price by Application (2015-2020) 12 Market Forecast 12.1 Global Pontine Glioma Drug Sales, Revenue and Growth Rate (2021-2025) 12.2 Pontine Glioma Drug Market Forecast by Regions (2021-2025) 12.2.1 North America Pontine Glioma Drug Market Forecast (2021-2025) 12.2.2 Europe Pontine Glioma Drug Market Forecast (2021-2025) 12.2.3 Asia-Pacific Pontine Glioma Drug Market Forecast (2021-2025) 12.2.4 South America Pontine Glioma Drug Market Forecast (2021-2025) 12.2.5 Middle East & Africa Pontine Glioma Drug Market Forecast (2021-2025) 12.3 Pontine Glioma Drug Market Forecast by Type (2021-2025) 12.3.1 Global Pontine Glioma Drug Sales Forecast by Type (2021-2025) 12.3.2 Global Pontine Glioma Drug Market Share Forecast by Type (2021-2025) 12.4 Pontine Glioma Drug Market Forecast by Application (2021-2025) 12.4.1 Global Pontine Glioma Drug Sales Forecast by Application (2021-2025) 12.4.2 Global Pontine Glioma Drug Market Share Forecast by Application (2021-2025) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source 15.3 Disclaimer 15.4 About US

List of Tables Table 1. Global Pontine Glioma Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Pontine Glioma Drug by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Pontine Glioma Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Market Opportunities in Next Few Years Table 5. Market Risks Analysis Table 6. Market Drivers Table 7. Arog Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors Table 8. Arog Pharmaceuticals, Inc. Pontine Glioma Drug Major Business Table 9. Arog Pharmaceuticals, Inc. Pontine Glioma Drug Total Revenue (USD Million) (2017-2018) Table 10. Arog Pharmaceuticals, Inc. SWOT Analysis Table 11. Arog Pharmaceuticals, Inc. Pontine Glioma Drug Product and Services Table 12. Arog Pharmaceuticals, Inc. Pontine Glioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 13. Medicenna Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors Table 14. Medicenna Therapeutics, Inc. Pontine Glioma Drug Major Business Table 15. Medicenna Therapeutics, Inc. Pontine Glioma Drug Total Revenue (USD Million) (2017-2018) Table 16. Medicenna Therapeutics, Inc. SWOT Analysis Table 17. Medicenna Therapeutics, Inc. Pontine Glioma Drug Product and Services Table 18. Medicenna Therapeutics, Inc. Pontine Glioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 19. Burzynski Research Institute, Inc. Basic Information, Manufacturing Base and Competitors Table 20. Burzynski Research Institute, Inc. Pontine Glioma Drug Major Business Table 21. Burzynski Research Institute, Inc. Pontine Glioma Drug Total Revenue (USD Million) (2017-2018) Table 22. Burzynski Research Institute, Inc. SWOT Analysis Table 23. Burzynski Research Institute, Inc. Pontine Glioma Drug Product and Services Table 24. Burzynski Research Institute, Inc. Pontine Glioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 25. Sanofi Basic Information, Manufacturing Base and Competitors Table 26. Sanofi Pontine Glioma Drug Major Business Table 27. Sanofi Pontine Glioma Drug Total Revenue (USD Million) (2017-2018) Table 28. Sanofi SWOT Analysis Table 29. Sanofi Pontine Glioma Drug Product and Services Table 30. Sanofi Pontine Glioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 31. Loxo Oncology, Inc. Basic Information, Manufacturing Base and Competitors Table 32. Loxo Oncology, Inc. Pontine Glioma Drug Major Business Table 33. Loxo Oncology, Inc. Pontine Glioma Drug Total Revenue (USD Million) (2017-2018) Table 34. Loxo Oncology, Inc. SWOT Analysis Table 35. Loxo Oncology, Inc. Pontine Glioma Drug Product and Services Table 36. Loxo Oncology, Inc. Pontine Glioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 37. Novogen Limited Basic Information, Manufacturing Base and Competitors Table 38. Novogen Limited Pontine Glioma Drug Major Business Table 39. Novogen Limited Pontine Glioma Drug Total Revenue (USD Million) (2017-2018) Table 40. Novogen Limited SWOT Analysis Table 41. Novogen Limited Pontine Glioma Drug Product and Services Table 42. Novogen Limited Pontine Glioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 43. Medivation, Inc. Basic Information, Manufacturing Base and Competitors Table 44. Medivation, Inc. Pontine Glioma Drug Major Business Table 45. Medivation, Inc. Pontine Glioma Drug Total Revenue (USD Million) (2017-2018) Table 46. Medivation, Inc. SWOT Analysis Table 47. Medivation, Inc. Pontine Glioma Drug Product and Services Table 48. Medivation, Inc. Pontine Glioma Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 49. Global Pontine Glioma Drug Sales by Manufacturer (2018-2019) (K Pcs) Table 50. Global Pontine Glioma Drug Revenue by Manufacturer (2018-2019) (USD Million) Table 51. Global Pontine Glioma Drug Sales by Regions (2015-2020) (K Pcs) Table 52. Global Pontine Glioma Drug Sales Market Share by Regions (2015-2020) Table 53. Global Pontine Glioma Drug Revenue by Regions (2015-2020) (USD Million) Table 54. North America Pontine Glioma Drug Sales by Countries (2015-2020) (K Pcs) Table 55. North America Pontine Glioma Drug Sales Market Share by Countries (2015-2020) Table 56. North America Pontine Glioma Drug Revenue by Countries (2015-2020) (USD Million) Table 57. North America Pontine Glioma Drug Revenue Market Share by Countries (2015-2020) Table 58. Europe Pontine Glioma Drug Sales by Countries (2015-2020) (K Pcs) Table 59. Europe Pontine Glioma Drug Sales Market Share by Countries (2015-2020) Table 60. Europe Pontine Glioma Drug Revenue by Countries (2015-2020) (USD Million) Table 61. Asia-Pacific Pontine Glioma Drug Sales by Regions (2015-2020) (K Pcs) Table 62. Asia-Pacific Pontine Glioma Drug Sales Market Share by Regions (2015-2020) Table 63. Asia-Pacific Pontine Glioma Drug Revenue by Regions (2015-2020) (USD Million) Table 64. South America Pontine Glioma Drug Sales by Countries (2015-2020) (K Pcs) Table 65. South America Pontine Glioma Drug Sales Market Share by Countries (2015-2020) Table 66. South America Pontine Glioma Drug Revenue by Countries (2015-2020) (USD Million) Table 67. South America Pontine Glioma Drug Revenue Market Share by Countries (2015-2020) Table 68. Middle East & Africa Pontine Glioma Drug Sales by Countries (2015-2020) (K Pcs) Table 69. Middle East & Africa Pontine Glioma Drug Sales Market Share by Countries (2015-2020) Table 70. Middle East & Africa Pontine Glioma Drug Revenue by Countries (2015-2020) (USD Million) Table 71. Middle East & Africa Pontine Glioma Drug Revenue Market Share by Countries (2015-2020) Table 72. Global Pontine Glioma Drug Sales by Type (2015-2020) (K Pcs) Table 73. Global Pontine Glioma Drug Sales Share by Type (2015-2020) Table 74. Global Pontine Glioma Drug Revenue by Type (2015-2020) (USD Million) Table 75. Global Pontine Glioma Drug Revenue Share by Type (2015-2020) Table 76. Global Pontine Glioma Drug Sales by Application (2015-2020) (K Pcs) Table 77. Global Pontine Glioma Drug Sales Share by Application (2015-2020) Table 78. Global Pontine Glioma Drug Sales Forecast by Regions (2021-2025) (K Pcs) Table 79. Global Pontine Glioma Drug Market Share Forecast by Regions (2021-2025) Table 80. Global Pontine Glioma Drug Sales Forecast by Type (2021-2025) (K Pcs) Table 81. Global Pontine Glioma Drug Market Share Forecast by Type (2021-2025) Table 82. Global Pontine Glioma Drug Sales Forecast by Application (2021-2025) Table 83. Global Pontine Glioma Drug Market Share Forecast by Application (2021-2025) Table 84. Direct Channel Pros & Cons Table 85. Indirect Channel Pros & Cons Table 86. Distributors/Traders/ Dealers List List of Figures Figure 1. Pontine Glioma Drug Picture Figure 2. Global Sales Market Share of Pontine Glioma Drug by Type in 2019 Figure 3. 8H-9 Picture Figure 4. A-10 Picture Figure 5. AdRTSIL-12 Picture Figure 6. Afatinib Dimaleate Picture Figure 7. AZD-1775 Picture Figure 8. Others Picture Figure 9. Pontine Glioma Drug Sales Market Share by Application in 2018 Figure 10. Clinic Picture Figure 11. Hospital Picture Figure 12. Others Picture Figure 13. Global Pontine Glioma Drug Market Status and Outlook (2015-2025) (USD Million) Figure 14. United States Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 15. Canada Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 16. Mexico Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 17. Germany Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 18. France Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 19. UK Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 20. Russia Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 21. Italy Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 22. China Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 23. Japan Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 24. Korea Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 25. India Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 26. Southeast Asia Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 27. Australia Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million) Figure 28. Brazil Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 29. Egypt Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 30. Saudi Arabia Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 31. South Africa Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 32. Turkey Pontine Glioma Drug Revenue (Value) and Growth Rate (2015-2025) Figure 33. Global Pontine Glioma Drug Sales Market Share by Manufacturer in 2019 Figure 34. Global Pontine Glioma Drug Revenue Market Share by Manufacturer in 2019 Figure 35. Top 3 Pontine Glioma Drug Manufacturer (Revenue) Market Share in 2019 Figure 36. Top 6 Pontine Glioma Drug Manufacturer (Revenue) Market Share in 2019 Figure 37. Key Manufacturer Market Share Trend Figure 38. Global Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 39. Global Pontine Glioma Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 40. Global Pontine Glioma Drug Revenue Market Share by Regions (2015-2020) Figure 41. Global Pontine Glioma Drug Revenue Market Share by Regions in 2018 Figure 42. North America Pontine Glioma Drug Sales and Growth Rate (2015-2020) Figure 43. Europe Pontine Glioma Drug Sales and Growth Rate (2015-2020) Figure 44. Asia-Pacific Pontine Glioma Drug Sales and Growth Rate (2015-2020) Figure 45. South America Pontine Glioma Drug Sales and Growth Rate (2015-2020) Figure 46. Middle East & Africa Pontine Glioma Drug Sales and Growth Rate (2015-2020) Figure 47. North America Pontine Glioma Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 48. North America Pontine Glioma Drug Sales Market Share by Countries (2015-2020) Figure 49. North America Pontine Glioma Drug Sales Market Share by Countries in 2018 Figure 50. North America Pontine Glioma Drug Revenue Market Share by Countries (2015-2020) (USD Million) Figure 51. North America Pontine Glioma Drug Revenue Market Share by Countries in 2018 Figure 52. United States Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 53. Canada Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 54. Mexico Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 55. Europe Pontine Glioma Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 56. Europe Pontine Glioma Drug Revenue Market Share by Countries (2015-2020) Figure 57. Europe Pontine Glioma Drug Revenue Market Share by Countries in 2019 Figure 58. Germany Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 59. UK Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 60. France Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 61. Russia Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 62. Italy Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 63. Asia-Pacific Pontine Glioma Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 64. Asia-Pacific Pontine Glioma Drug Sales Market Share by Regions 2019 Figure 65. Asia-Pacific Pontine Glioma Drug Revenue Market Share by Regions 2019 Figure 66. China Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 67. Japan Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 68. Korea Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 69. India Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 70. Southeast Asia Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 71. South America Pontine Glioma Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 72. South America Pontine Glioma Drug Sales Market Share by Countries in 2019 Figure 73. South America Pontine Glioma Drug Revenue Market Share by Countries in 2019 Figure 74. Brazil Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 75. Argentina Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 76. Middle East and Africa Pontine Glioma Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 77. Middle East and Africa Pontine Glioma Drug Sales Market Share by Countries in 2019 Figure 78. Middle East and Africa Pontine Glioma Drug Revenue Market Share by Countries (2015-2020) Figure 79. Middle East and Africa Pontine Glioma Drug Revenue Market Share by Countries in 2019 Figure 80. Saudi Arabia Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 81. Egypt Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 82. Turkey Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 83. South Africa Pontine Glioma Drug Sales and Growth Rate (2015-2020) (K Pcs) Figure 84. Global Pontine Glioma Drug Sales and Growth Rate (2021-2025) (K Pcs) Figure 85. Global Pontine Glioma Drug Revenue and Growth Rate (2021-2025) (USD Million) Figure 86. North America Sales Pontine Glioma Drug Market Forecast (2021-2025) (K Pcs) Figure 87. Europe Sales Pontine Glioma Drug Market Forecast (2021-2025) (K Pcs) Figure 88. Asia-Pacific Sales Pontine Glioma Drug Market Forecast (2021-2025) (K Pcs) Figure 89. South America Sales Pontine Glioma Drug Market Forecast (2021-2025) (K Pcs) Figure 90. Middle East & Africa Sales Pontine Glioma Drug Market Forecast (2021-2025) (K Pcs) Figure 91. Sales Channel: Direct Channel vs Indirect Channel

Arog Pharmaceuticals, Inc. Medicenna Therapeutics, Inc. Burzynski Research Institute, Inc. Sanofi Loxo Oncology, Inc. Novogen Limited Medivation, Inc.